These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8107326)

  • 21. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
    Wong PC; Quan ML; Saye JM; Bernard R; Crain EJ; McCall DE; Watson CA; Zaspel AM; Smith RD; Wexler RR
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):354-62. PubMed ID: 8583775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
    Keiser JA; Ryan MJ; Panek RL; Hodges JC; Sircar I
    J Pharmacol Exp Ther; 1995 Mar; 272(3):963-9. PubMed ID: 7891350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
    Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.
    Okunishi H; Song K; Oka Y; Kobayashi T; Kawamoto T; Ishihara H; Mori N; Miyazaki M
    Jpn J Pharmacol; 1993 Jul; 62(3):239-44. PubMed ID: 8411773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist.
    Wong YN; Wong PC
    J Pharm Pharmacol; 1996 May; 48(5):492-7. PubMed ID: 8799873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist.
    Tamura K; Okuhira M; Amano H; Inokuma K; Hirata T; Mikoshiba I; Hashimoto K
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):607-15. PubMed ID: 9388043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central and peripheral actions of a nonpeptidic angiotensin II receptor antagonist.
    Koepke JP; Bovy PR; McMahon EG; Olins GM; Reitz DB; Salles KS; Schuh JR; Trapani AJ; Blaine EH
    Hypertension; 1990 Jun; 15(6 Pt 2):841-7. PubMed ID: 2190928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor.
    Teng J; Fukuda N; Suzuki R; Takagi H; Ikeda Y; Tahira Y; Kanmatsuse K
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):161-71. PubMed ID: 11791001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
    McMahon EG; Yang PC; Babler MA; Suleymanov OD; Palomo MA; Olins GM; Cook CS
    Am J Hypertens; 1997 Jun; 10(6):671-7. PubMed ID: 9194514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors.
    Kawano K; Fujishima K; Nagura J; Yasuda S; Shinki ; Hachisu M; Konno F
    Eur J Pharmacol; 1998 Sep; 357(1):33-9. PubMed ID: 9788771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
    Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
    Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on nonpeptide angiotensin II receptor antagonists. III. Synthesis and biological evaluation of 5-alkylidene-3,5-dihydro-4H-imidazol-4-one derivatives.
    Okazaki T; Kikuchi K; Watanabe T; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):777-81. PubMed ID: 9621411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
    Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.
    Tofovic SP; Pong AS; Jackson EK
    Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel angiotensin receptor subtypes in fowl.
    Nishimura H; Walker OE; Patton CM; Madison AB; Chiu AT; Keiser J
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    Chang RS; Siegl PK; Clineschmidt BV; Mantlo NB; Chakravarty PK; Greenlee WJ; Patchett AA; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):133-8. PubMed ID: 1625192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.